Ethical Limits On Exclusion Based On Biomarkers.

ethical limits on exclusion based on biomarkers

1. introduction

Exclusion based on biomarkers refers to the practice of denying, restricting or limiting an individual's access to employment, healthcare, insurance, education, research participation or other social opportunities because of particular biological indicators.

Biomarkers are measurable biological characteristics that indicate normal biological processes, disease conditions, genetic susceptibility, physiological changes or responses to medical treatment. They may include genetic markers, blood-based indicators, hormonal measurements, neurological indicators, molecular signatures and other biological measurements.

Biomarker-based exclusion may occur when employers, healthcare institutions, insurance companies, research organizations or other authorities use biological information to classify individuals as unsuitable, unhealthy, high-risk or less capable.

Although biomarkers can support disease prevention, personalized medicine and clinical decision-making, their misuse can create discrimination, privacy violations and social inequality.

For example, an individual may be denied employment because a biomarker indicates a possible future disease, even though the individual is currently healthy and capable of performing the job.

The ethical challenge is to distinguish legitimate medical decisions based on scientifically established evidence from discriminatory exclusion based on biological characteristics or uncertain predictions.

2. meaning and scope of biomarker-based exclusion

Biomarker-based exclusion involves using biological information as a ground for denying or restricting opportunities.

Its major forms include:

Genetic exclusion: Denying opportunities because of inherited genetic characteristics or disease susceptibility.

Medical exclusion: Restricting access to employment or services because of biomarkers associated with particular medical conditions.

Insurance exclusion: Denying coverage or imposing discriminatory conditions based on biological risk indicators.

Employment exclusion: Rejecting candidates because biomarkers suggest potential future health problems.

Educational exclusion: Restricting participation in educational activities based on biological or neurological indicators.

Research exclusion: Excluding individuals from clinical studies because of biomarker classifications without adequate scientific or ethical justification.

Social exclusion: Treating individuals as inferior or undesirable because of their biological characteristics.

Such practices raise concerns regarding equality, human dignity, privacy, bodily autonomy and the right to participate equally in society.

3. ethical principles governing biomarker-based exclusion

A. Equality and non-discrimination

Individuals should not be treated unfairly merely because they possess particular biological characteristics. Biomarker information should not become an instrument of social discrimination.

B. Human dignity

Every individual possesses inherent human dignity regardless of genetic composition, disease susceptibility or physiological characteristics.

C. Privacy and confidentiality

Biological information is highly personal. Its collection, storage, analysis and disclosure must be governed by appropriate privacy protections.

D. Scientific validity

Exclusion decisions must not rely on inaccurate, incomplete or scientifically unvalidated biomarkers. A biological association does not automatically establish that an individual is incapable or unsuitable.

E. Informed consent

Individuals should understand why their biomarkers are being collected, how the information will be used and whether disclosure is voluntary or legally required.

F. Proportionality

Any restriction based on biomarkers must be necessary, proportionate and supported by reliable evidence. Less restrictive alternatives should be considered.

G. Fairness and social justice

Biomarker-based classifications must not reinforce existing social inequalities or create a biological hierarchy between individuals.

4. legal framework in India

India does not have a comprehensive standalone law specifically prohibiting every form of biomarker-based discrimination. However, constitutional protections, disability legislation, privacy principles and insurance regulations provide relevant safeguards.

A. Constitution of India

Article 14: Guarantees equality before the law and equal protection of laws. Arbitrary exclusion based on biological characteristics may violate this provision.

Article 15: Prohibits discrimination on specified grounds. It may be relevant where biomarker-based exclusion is connected with a protected ground.

Article 21: Protects life, personal liberty, privacy, dignity and bodily autonomy.

Article 16: Provides equality of opportunity in public employment.

Article 41: Directs the State to make provisions for public assistance in cases of sickness and disability, subject to its economic capacity.

B. Rights of Persons with Disabilities Act, 2016

The Act prohibits disability-based discrimination and recognizes reasonable accommodation. Biomarker results should not automatically be treated as proof of disability or professional incapacity.

C. Digital Personal Data Protection Act, 2023

The Act provides a framework for processing digital personal data, including applicable obligations concerning lawful processing, consent and protection of personal information. Its applicability depends on the nature of the data and processing involved.

D. Insurance Regulatory Framework

Insurance companies must comply with applicable IRDAI regulations and directions. Broad or arbitrary exclusions based on genetic conditions raise concerns about fairness, transparency and access to healthcare.

E. Medical Research Ethics

ICMR ethical guidelines require appropriate consent, confidentiality, scientific validity and protection of research participants when biological information is collected or used in medical research.

5. relevant case laws

1. United India Insurance Co. Ltd. v. Jai Parkash Tayal (Delhi High Court, 2018)

Facts: The dispute concerned rejection of a health insurance claim on the basis of an exclusion relating to genetic disorders.

Judgment: The Delhi High Court held that the broad exclusion of genetic disorders was unreasonable and discriminatory. It emphasized that insurance decisions should be based on empirical evidence rather than vague assumptions about genetic conditions.

Legal principle: Arbitrary exclusion based on genetic disposition raises constitutional concerns involving equality and the right to health.

Relevance: This is particularly important for biomarker-based exclusion because genetic biomarkers may indicate susceptibility to disease without establishing that the individual currently suffers from that disease.

Important qualification: The Supreme Court, in United India Insurance Co. Ltd. v. Jai Parkash Tayal (order dated 27 August 2018), issued notice and stayed the operation of the relevant conclusions and relief granted by the Delhi High Court until further orders. Therefore, the Delhi High Court's findings should not be presented as an affirmed final Supreme Court ruling.

2. Dr. Shanthi Rengarajan v. The Oriental Insurance Company Ltd. (Madras High Court, 2018)

Facts: The case concerned the rejection of a health insurance claim under an exclusion relating to genetic disorders.

Judgment: The Madras High Court examined the reasonableness of genetic-disorder exclusions and emphasized that genetic heritage should not automatically become a ground for denying health insurance benefits.

Legal principle: Insurance exclusions must have a reasonable and scientifically supportable basis and should not operate as arbitrary discrimination.

Relevance: The judgment provides an important judicial discussion of genetic discrimination. It supports the ethical argument that biological risk indicators should not automatically justify exclusion from healthcare protection.

3. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) 10 SCC 1

Facts: The case concerned the constitutional status of the right to privacy.

Judgment: The Supreme Court unanimously recognized privacy as a fundamental right under Article 21 and other constitutional freedoms.

Legal principle: Privacy includes bodily integrity, informational privacy and decisional autonomy.

Relevance: Biomarkers can reveal highly sensitive information about disease susceptibility, reproductive health, genetic composition and physiological conditions. Their unauthorized collection or disclosure may violate individual privacy and dignity.

4. Vikash Kumar v. Union Public Service Commission (2021) 5 SCC 370

Facts: The case concerned the denial of a scribe facility to a candidate with a specified disability who required reasonable accommodation.

Judgment: The Supreme Court emphasized that reasonable accommodation is an essential component of substantive equality and that disability-related needs must be considered individually.

Legal principle: Equality requires more than identical treatment; appropriate accommodation may be necessary to ensure meaningful participation.

Relevance: Individuals should not be excluded from employment, education or institutional opportunities merely because a biomarker indicates a biological difference. Individual abilities and reasonable accommodation must be considered.

5. Chief Commissioner for Persons with Disabilities v. State of Karnataka (2024)

This reference is not relied upon as a separately verified biomarker-discrimination precedent. The more established authority for the relevant principle is Vikash Kumar v. UPSC (2021).

The applicable legal principle is that biological or medical differences should not automatically justify exclusion where reasonable accommodation can enable participation.

6. National Legal Services Authority v. Union of India (2014) 5 SCC 438

Facts: The case concerned the recognition of transgender persons and protection of their constitutional rights.

Judgment: The Supreme Court recognized gender identity as an essential aspect of personal identity and affirmed constitutional protections against discrimination.

Legal principle: Human dignity, individual identity and equality must be respected in the treatment of individuals.

Relevance: Biomarker classifications should not be used to impose rigid biological categories or deny individuals equal treatment and social participation.

6. major ethical and legal challenges

A. Genetic discrimination

Employers and insurers may use genetic biomarkers to exclude individuals based on predicted future illnesses rather than actual medical conditions.

B. False-positive results

An inaccurate biomarker result may lead to unjustified exclusion and long-term reputational or economic harm.

C. Employment inequality

Individuals may be denied employment despite possessing the necessary qualifications and ability to perform their duties.

D. Insurance discrimination

Biomarker-based risk classification may result in unfair denial of coverage, unreasonable exclusions or discriminatory insurance conditions.

E. Privacy violations

Unauthorized access to biological information may expose individuals to discrimination, exploitation and social stigma.

F. Scientific uncertainty

Many biomarkers indicate probability rather than certainty. Treating a statistical association as conclusive evidence of incapacity creates serious ethical problems.

G. Social stigmatization

Biological classification may create distinctions between individuals considered biologically desirable and those considered biologically undesirable.

7. preventive measures and safeguards

Prohibit arbitrary exclusion based on genetic and biological characteristics.

Require scientific validation before using biomarkers in important institutional decisions.

Ensure informed consent before collecting sensitive biological information.

Establish strict confidentiality and data-protection standards.

Require individualized assessments rather than automatic biological classifications.

Provide mechanisms for challenging inaccurate biomarker results.

Prohibit discriminatory employment decisions based solely on speculative future disease risks.

Ensure transparent and reasonable insurance underwriting practices.

Provide reasonable accommodation wherever applicable.

Establish independent oversight of biomarker-based decision-making systems.

Introduce compensation mechanisms for unlawful discrimination and misuse of biological information.

Promote equal access to healthcare and research opportunities.

8. conclusion

Ethical limits on exclusion based on biomarkers are essential for protecting human dignity, equality, privacy and social justice. Biomarkers can provide valuable information for medical diagnosis, disease prevention and personalized healthcare. However, their use as instruments of exclusion may create genetic discrimination, employment inequality, insurance injustice and social stigmatization.

Indian constitutional jurisprudence provides important foundations for preventing arbitrary biological discrimination. The decisions in Jai Parkash Tayal, Shanthi Rengarajan, Puttaswamy and Vikash Kumar offer relevant principles concerning genetic discrimination, privacy, equality and reasonable accommodation, although their legal scope and precedential status differ.

Ultimately, no individual should be considered socially, professionally or economically inferior merely because of a biological marker. Biomarker-based decisions must be scientifically justified, proportionate, transparent and consistent with constitutional rights.

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT